Several potential disease-modifying drugs for Alzheimer's disease (AD) have failed to show
any effect on disease progression in clinical trials, conceivably because the AD subjects are …

Estrogen is a fundamental regulator of the metabolic system of the female brain and body.
Within the brain, estrogen regulates glucose transport, aerobic glycolysis, and mitochondrial …

Alzheimer's disease is an incurable, progressive neurological brain disorder. Earlier
detection of Alzheimer's disease can help with proper treatment and prevent brain tissue …

For the last decade, it has been shown that neuroimaging can be a potential tool for the
diagnosis of Alzheimer's Disease (AD) and its prodromal stage, Mild Cognitive Impairment …

Alzheimer's disease (AD) will become a global burden in the coming decades according to
the latest statistical survey. How to effectively detect AD or MCI (mild cognitive impairment) …

Effective and accurate diagnosis of Alzheimer's disease (AD), as well as its prodromal stage
(ie, mild cognitive impairment (MCI)), has attracted more and more attention recently. So far …

Many machine learning and pattern classification methods have been applied to the
diagnosis of Alzheimer's disease (AD) and its prodromal stage, ie, mild cognitive impairment …

Alzheimer's disease (AD), the most common form of dementia, shares many aspects of
abnormal brain aging. We present a novel magnetic resonance imaging (MRI)-based …

Decades of experimental and clinical research have contributed to unraveling many
mechanisms in the pathogenesis of Alzheimer's disease (AD), but the puzzle is still …

The accurate diagnosis of Alzheimer's disease (AD) and its early stage, eg, mild cognitive
impairment (MCI), is essential for timely treatment or possible intervention to slow down AD …